Skip to main content
Journal ArticleOPEN ACCESS

Use of Percutaneous Ethanol Injection Therapy for Recurrent Secondary Hyperparathyroidism after Subtotal Parathyroidectomy

  • Douthat W
  • Cardozo G
  • Garay G
  • et al.
International Journal of Nephrology (2011) 2011 1-6
DOI: 10.4061/2011/246734
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We evaluated the efficacy of percutaneous ethanol injection therapy (PEIT) as a therapeutic option for recurrence of secondary hyperparathyroidism after subtotal parathyroidectomy in ESRD patients. Six patients underwent PEIT. A mean of 1.3 ± 0.8 ethanol injections was performed. Nodular volume was 1.5 ± 1.7 cm 3 , and 2.8 ± 2.8 cm 3 of ethanol was injected per patient. After ethanol injection PTH decreased significantly (1897 ± 754 to 549 ± 863 pg/mL ( P

Cite

CITATION STYLE

APA

Douthat, W. G., Cardozo, G., Garay, G., Orozco, S., Chiurchiu, C., de la Fuente, J., … Massari, P. U. (2011). Use of Percutaneous Ethanol Injection Therapy for Recurrent Secondary Hyperparathyroidism after Subtotal Parathyroidectomy. International Journal of Nephrology, 2011, 1–6. https://doi.org/10.4061/2011/246734

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free